Aging and cerebrovascular dysfunction: contribution of hypertension, cerebral amyloid angiopathy, and immunotherapy - Wikidata - awgldk - TriplyDB

Aging and cerebrovascular dysfunction: contribution of hypertension, cerebral amyloid angiopathy, and immunotherapy

Aging and cerebrovascular dysfunction: contribution of hypertension, cerebral amyloid angiopathy, and immunotherapy

http://www.wikidata.org/entity/Q34219814

about

Impact of age-related neuroglial cell responses on hippocampal deterioration Evolving management of symptomatic chronic subdural hematoma: experience of a single institution and review of the literature Impact of postprandial glycaemia on health and prevention of disease The transcriptome of cerebral ischemia Neuroinflammation and cerebrovascular disease in old age: a translational medicine perspective Maintaining brain health by monitoring inflammatory processes: a mechanism to promote successful aging Cholesterol in brain disease: sometimes determinant and frequently implicated.Phenotypic and gene expression modification with normal brain aging in GFAP-positive astrocytes and neural stem cells.Gender and age interact to affect early outcome after intracerebral hemorrhage Therapeutic modulation of cerebral microhemorrhage in a mouse model of cerebral amyloid angiopathy.Modeling the Role of the Glymphatic Pathway and Cerebral Blood Vessel Properties in Alzheimer's Disease Pathogenesis.Translating basic science research to clinical application: models and strategies for intracerebral hemorrhage.Extensive innate immune gene activation accompanies brain aging, increasing vulnerability to cognitive decline and neurodegeneration: a microarray study Age-related decrease in cerebrovascular-derived neuroprotective proteins: effect of acetaminophen Cessation of neoangiogenesis in Alzheimer's disease follows amyloid-beta immunization The association between small vessel infarcts and the activities of amyloid-β peptide degrading proteases in apolipoprotein E4 allele carriers.Endothelial nitric oxide deficiency promotes Alzheimer's disease pathology Is Alzheimer's disease amyloidosis the result of a repair mechanism gone astray?Risks and benefits of CT angiography in spontaneous intracerebral hemorrhage Etiologies of intracerebral hematomas.Assessment of the interaction of age and sex on 90-day outcome after intracerebral hemorrhage.Cerebral Vascular Control and Metabolism in Heat Stress.Age and Chronicity of Administration Dramatically Influenced the Impact of Low Dose Paraquat Exposure on Behavior and Hypothalamic-Pituitary-Adrenal Activity.Pharmacological modulation of dietary lipid-induced cerebral capillary dysfunction: Considerations for reducing risk for Alzheimer's disease.Blood-brain barrier and blood-cerebrospinal fluid barrier in normal and pathological conditions.The blood clotting Factor XIIIa forms unique complexes with amyloid-beta (Aβ) and colocalizes with deposited Aβ in cerebral amyloid angiopathy.Common Impact of Chronic Kidney Disease and Brain Microhemorrhages on Cerebral Aβ Pathology in SHRSP.Comparative analysis of H&E and Prussian blue staining in a mouse model of cerebral microbleeds.The impaired synthesis of insulin and its inability to inhibit platelet aggregation in cerebrovascular accident.

P2860

Q26825419-EFD89DAD-7F59-4047-AB29-26CFAB9A26A7 Q26862513-43028128-3F50-4AFC-B710-093518129781 Q26862823-2CEF036B-0E2F-4E1F-8BF7-4BEC106C773A Q27015999-C9EE002E-BD7B-4D42-B9A8-D392641C7ADC Q28393202-69F96E07-9D28-47B4-A854-B6CF57E8BF1F Q28730725-9FD999A9-987E-484F-927F-0C73AE42D554 Q34621446-C359DF5A-39B3-4118-9A2F-D3F2CC81711A Q34981292-05890823-6144-4941-9766-3A39ABE532AD Q35060644-4ACBD9C2-375C-411F-AB2D-C6DE608E50F5 Q35565914-CB8B2A8B-0960-4E94-9512-28F92F8ADCCB Q35800921-24BCE7E7-EA0F-4076-9C93-8940C1DCD457 Q35993214-BD18D715-D20F-4B48-A36B-161F440157B1 Q36164195-841B453E-7519-414A-B987-19ED4E078A4B Q36354157-344C7903-BAC5-471C-8891-97C307FE0806 Q36644869-12DEC870-A34E-4579-9249-E9DE2F488570 Q37211285-39580D90-1F6B-4E3B-9C5B-2990660CED63 Q37302801-1CAB6C32-C7F3-46FF-B885-E8A4575D4153 Q37698598-F153D93E-A702-4C98-B3F6-E83915B925BB Q37705693-BC4D7149-9489-4665-A13A-2ED4788A2F86 Q38007885-D25A30D3-F746-4F80-A0EA-42FC04EDECE4 Q38373924-D2B3C1FC-1808-438B-B9FF-F1FCFBC7AB2A Q38542457-F0AB033D-C647-4EA9-B21C-72236DF0DAB5 Q38645679-174EF69B-0797-447B-AA29-D853D42B9DF3 Q38672178-92A124F4-E88F-443C-AFC3-1D55D0EF8741 Q38752185-5EDE418D-8344-4C39-AC9A-BDD6A4509AFA Q41076513-5C94D5D1-E083-4D89-895C-B80DDB3519E3 Q44413015-1658532F-0AA7-44C5-A879-E3711CD8241F Q46852523-44A1CA86-B2FB-40A8-B795-515C067FB3D8 Q52151869-1BF6A0FF-E17C-4C33-8993-EFC048B656E0

P2860

Aging and cerebrovascular dysfunction: contribution of hypertension, cerebral amyloid angiopathy, and immunotherapy

http://www.wikidata.org/entity/Q34219814

description

2010 nî lūn-bûn

@nan

2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Aging and cerebrovascular dysf ...... angiopathy, and immunotherapy

@ast

Aging and cerebrovascular dysf ...... angiopathy, and immunotherapy

@en

Aging and cerebrovascular dysf ...... angiopathy, and immunotherapy

@nl

type

label

Aging and cerebrovascular dysf ...... angiopathy, and immunotherapy

@ast

Aging and cerebrovascular dysf ...... angiopathy, and immunotherapy

@en

Aging and cerebrovascular dysf ...... angiopathy, and immunotherapy

@nl

prefLabel

Aging and cerebrovascular dysf ...... angiopathy, and immunotherapy

@ast

Aging and cerebrovascular dysf ...... angiopathy, and immunotherapy

@en

Aging and cerebrovascular dysf ...... angiopathy, and immunotherapy

@nl

P1433

Q34219814-5910B661-D2F7-40E7-828F-4857A9EE6571

P1476

Q34219814-7C8C51F6-0805-48D8-8FE6-EA89D02958AE

P2093

Q34219814-278AE59A-9109-4A63-BBFA-7CAA02963146

Q34219814-4AB126B3-9AE4-473E-897F-EA2E421D0481

Q34219814-819BA075-9FFB-461F-9B95-50DF0B686EC7

Q34219814-86224FD8-2440-48EC-BC26-24C01C97FAF0

Q34219814-A0FDC497-F589-430D-9E1B-F94A0A5E75C5

Q34219814-D68E61A1-DC2B-47DE-8AE3-592B8CBBE89D

Q34219814-DF049260-FDA8-4EA9-A1D4-61833AF6EC69

P2860

Q34219814-093A12FA-D977-476C-A528-956FFF235F3A

Q34219814-0AB88800-D1F1-4166-9884-433D84631EE0

Q34219814-0BD1AFC3-6B70-4C6E-8A07-3DE9A81D7865

Q34219814-168C51E4-3719-40BB-A511-8D12BD861610

Q34219814-1905B5A1-D530-404C-83FD-1BAF540D38D8

Q34219814-197FA745-D077-4C4D-8BB9-F621D0244283

Q34219814-19BB120B-FC9F-430F-9A9D-AE976A3C2B5A

Q34219814-202F17A3-86BB-483B-A323-F434C0BA625E

Q34219814-226DDBF9-3910-4F02-9B50-76B23DF46717

Q34219814-228D671D-6F54-4353-A53A-4512FFA0178E

P304

Q34219814-6ECD2258-D1EE-4058-90C1-0D4B8D0054B0

P31

Q34219814-25774B84-7798-4415-A67B-FA97EAB2A895

P356

Q34219814-521857D7-4243-44F2-914A-2CBC10E916F2

P407

Q34219814-1CF89AD3-DF16-45A1-BAED-F4983E08890A

P478

Q34219814-9D1BD0B9-1147-4A00-9071-BF198EDF6A60

P577

Q34219814-A9636AB9-B499-4812-8016-041C93F45570

P5875

Q34219814-365FBB71-A2C2-442E-A0CA-7F111A3021C1

P698

Q34219814-DD6BD628-1382-4C7A-8118-68D69CA87F1C

P921

Q34219814-629C4D89-7EC3-4C43-9D36-A38A9016B2DE

P932

Q34219814-512B59D1-BC66-4E93-A0D1-C0902A5434FE

P356

J.1749-6632.2010.05786.X

P1433

Annals of the New York Academy of Sciences

P1476

Aging and cerebrovascular dysf ...... angiopathy, and immunotherapy

@en

P2093

Daniel Quiring

http://www.w3.org/2001/XMLSchema#string

David H Cribbs

http://www.w3.org/2001/XMLSchema#string

Elizabeth Head

http://www.w3.org/2001/XMLSchema#string

Giselle F Passos

http://www.w3.org/2001/XMLSchema#string

Mark Fisher

http://www.w3.org/2001/XMLSchema#string

Richard C Kim

http://www.w3.org/2001/XMLSchema#string

Vitaly Vasilevko

http://www.w3.org/2001/XMLSchema#string

P2860

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

Apolipoprotein E and Alzheimer disease

Threats to the mind: aging, amyloid, and hypertension

Passive immunotherapy against Abeta in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins

Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization

The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease

P304

58-70

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1749-6632.2010.05786.X

http://www.w3.org/2001/XMLSchema#string

P407

P478

1207

http://www.w3.org/2001/XMLSchema#string

P577

2010-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47458436

http://www.w3.org/2001/XMLSchema#string

P698

20955427

http://www.w3.org/2001/XMLSchema#string

P921

P932

2958685

http://www.w3.org/2001/XMLSchema#string